T. Rowe Price Associates’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-20,606
| Closed | -$190K | – | 2630 |
|
|
2017
Q1 | $190K | Buy |
20,606
+19
| +0.1% | +$175 | ﹤0.01% | 2404 |
|
|
2016
Q4 | $159K | Buy |
+20,587
| New | +$159K | ﹤0.01% | 2417 |
|
|
2015
Q1 | – | Sell |
-45,500
| Closed | -$990K | – | 2626 |
|
|
2014
Q4 | $990K | Sell |
45,500
-82,253
| -64% | -$1.79M | ﹤0.01% | 1723 |
|
|
2014
Q3 | $2.42M | Buy |
127,753
+75,717
| +146% | +$1.43M | ﹤0.01% | 1551 |
|
|
2014
Q2 | $1.21M | Buy |
+52,036
| New | +$1.21M | ﹤0.01% | 1679 |
|
|
2013
Q4 | – | Sell |
-69,900
| Closed | -$1.07M | – | 2584 |
|
|
2013
Q3 | $1.07M | Buy |
+69,900
| New | +$1.07M | ﹤0.01% | 1651 |
|